[Form 4] Tivic Health Systems, Inc. Insider Trading Activity
Jennifer Ernst, who is listed as both Chief Executive Officer and a director of Tivic Health Systems, Inc. (TIVC), reported a non-derivative acquisition of 22,541 shares of common stock with a reported price of $0, resulting in total beneficial ownership of 23,247 shares after the transaction. The filing indicates the report was made by a single reporting person and reflects an insider equity grant or transfer rather than a market purchase.
- Insider acquisition reported: CEO and director acquired 22,541 common shares, increasing her stake to 23,247 shares, which may align executive and shareholder interests.
- None.
Insights
TL;DR: CEO and director received an equity grant increasing her ownership modestly, aligning leadership with shareholder interests.
The reported acquisition appears to be a non-cash equity grant or similar internal issuance given the $0 price, which is a common mechanism to compensate executives or vest previously awarded awards. As both CEO and director, the reporting person’s increased ownership can signal alignment of management incentives with long-term shareholder value. The absolute size—23,247 shares beneficially owned post-transaction—is small to moderate depending on the company’s outstanding share count; the filing provides no percentage ownership, so materiality relative to total shares outstanding cannot be assessed from this document alone.
TL;DR: Non-derivative acquisition at $0 suggests internal grant; impact on float and valuation is likely immaterial without outstanding share context.
The transaction code and $0 price indicate an internal issuance such as vesting of restricted stock or a direct grant rather than an open-market purchase. For investors, the key takeaway is insider ownership modestly increased, which can be viewed positively for alignment but does not on its own imply a material change to capitalization or liquidity. The form discloses post-transaction beneficial ownership of 23,247 shares, but without total shares outstanding or percentage ownership this filing alone cannot quantify dilution or signalling magnitude.